Groupe la Francaise »

Atrium Therapeutics shares owned by Groupe la Francaise

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Groupe la Francaise from 13F filings

Historical chart of Groupe la Francaise investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Groupe la Francaise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Groupe la Francaise

Quarter filed Position value Share count Share price at filing
2026-03-31 $397k 30k 13.37

More positions owned by Groupe la Francaise

Totalenergies Se Act (TTE)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Astrazeneca Ord (AZN)
JPMorgan Chase & Co. (JPM)
Cgi Cl A Sub Vtg (GIB)
Visa Com Cl A (V)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl C (GOOG)
Ferrari Nv Ord (RACE)
Meta Platforms Cl A (META)

View all positions for Groupe la Francaise

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics